OH Epic Formulary, available via therapy plan, restricted to:

• Indication: as an adjunct for intraoperative identification of malignant lesions in adult patients with ovarian cancer, and malignant and non-malignant pulmonary lesions in adult patients with known or suspected cancer in the lung.
• Service line: Thoracic Surgery, Gynecologic Oncology
• Formulary location: Inpatient
• Service location: Surgery
• Patient population: Adults
• Prior authorization required: No
• Restriction/criteria of use (all will apply unless specified):
• For females of reproductive potential: negative pregnancy test prior to administration
• Discontinuation of folate, folic acid, or folate containing supplements 48 hours before administration of Cytalux
• Adequate renal and liver function (i.e., CrCl ≥ 30 mL/minute, total bilirubin < 3 times the upper limit of normal (ULN) and aspartate aminotransferase (AST) > ULN))

• UpToDate
• Lexicomp
• DailyMed Package Inserts
• Johns Hopkins Guides